Here, we further contributed to the field by unraveling novel immune correlates associated with better metabolic responsiveness of type 1 diabetes patients to AHSCT: decreased effector-memory CD4+ T cells, expansion of immunoregulatory T cells, and lower frequencies of islet-specific autoreactive CTLs. Here, CD4 is linked to type 1 diabetes mellitus.